Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity
- PMID: 9640364
- DOI: 10.1046/j.1365-2133.1998.02169.x
Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity
Abstract
Few and contrasting data are available in the literature concerning the levels of various cytokines in blister fluid (BF) and in the serum of patients affected with bullous pemphigoid (BP). Using commercially available ELISA kits, this study reports the levels of 11 cytokines detected both in BF and sera of 15 BP patients and compares them with those of 15 control subjects' sera. Generally, no significant differences were observed in BP and control sera. In contrast, interleukin (IL) 1 beta, IL-2, IL-4, IL-5, IL-6, IL-8, tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) showed increased BF levels as compared with BP sera. Two cytokines, IL-11 and IL-12 did not show significant differences between BP BF and sera, while an opposite behaviour was observed for transforming growth factor beta 1 (TGF-beta 1), whose serum levels were higher than the concentrations in BF. Using the number of lesions of the patients as a possible disease intensity marker, significant correlations were found with the BF levels of IL-1 beta, IL-8, TNF-alpha and, most closely, IL-5. These data may have pathogenetic relevance and suggest the possibility that these biological modulators may be used as a quantitative marker of disease intensity.
Similar articles
-
Decreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10.Exp Dermatol. 1998 Aug;7(4):157-61. doi: 10.1111/j.1600-0625.1998.tb00317.x. Exp Dermatol. 1998. PMID: 9758411
-
Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity.J Eur Acad Dermatol Venereol. 1999 Jan;12(1):11-5. J Eur Acad Dermatol Venereol. 1999. PMID: 10188143
-
Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.Cytokine. 2000 Jul;12(7):1076-83. doi: 10.1006/cyto.1999.0642. Cytokine. 2000. PMID: 10880254
-
Cytokines and bullous pemphigoid.Eur Cytokine Netw. 1999 Jun;10(2):123-34. Eur Cytokine Netw. 1999. PMID: 10400817 Review.
-
Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid.Autoimmun Rev. 2019 May;18(5):526-534. doi: 10.1016/j.autrev.2019.03.009. Epub 2019 Mar 4. Autoimmun Rev. 2019. PMID: 30844553
Cited by
-
Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid.Front Immunol. 2019 Aug 7;10:1858. doi: 10.3389/fimmu.2019.01858. eCollection 2019. Front Immunol. 2019. PMID: 31440247 Free PMC article.
-
Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid.Front Immunol. 2019 Mar 29;10:636. doi: 10.3389/fimmu.2019.00636. eCollection 2019. Front Immunol. 2019. PMID: 31001258 Free PMC article. Clinical Trial.
-
Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study.Medicine (Baltimore). 2019 Feb;98(7):e14514. doi: 10.1097/MD.0000000000014514. Medicine (Baltimore). 2019. PMID: 30762788 Free PMC article.
-
Granzyme B inhibition reduces disease severity in autoimmune blistering diseases.Nat Commun. 2021 Jan 12;12(1):302. doi: 10.1038/s41467-020-20604-3. Nat Commun. 2021. PMID: 33436591 Free PMC article.
-
Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement.Int J Mol Sci. 2022 Dec 24;24(1):323. doi: 10.3390/ijms24010323. Int J Mol Sci. 2022. PMID: 36613766 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous